Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Chronic Pain × Ropivacaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Pain 3 Pain, Postoperative 2 Agnosia 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Postoperative Complications 1 Ovarian Cysts 1 Neoplasms 1 Malignant Neoplasms of Male Genital Organs 1 Intraoperative Complications 1 Goiter 1 Colorectal Neoplasms 1 Chronic Pain 1 Carcinoma, Renal Cell 1 Advanced Ovarian Cancer 1 Abdominal Neoplasms 1

Interventions

Sodium Chloride 2 Tapentadol 1 Ropivacaine 1 Pregabalin 1 Meloxicam 1 Lidocaine 1 Ketorolac Tromethamine 1 Ketorolac 1 Ketamine 1 Fentanyl 1 Educational Status 1 Anti-Inflammatory Agents, Non-Steroidal 1 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02408393 2019-07-10

MIRs03

Institut Curie

Phase 3 Completed

Breast Neoplasms, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡